TELA Bio
TELA
50 hedge funds and large institutions have $30M invested in TELA Bio in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 11 closing their positions.
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
6% more funds holding
Funds holding: 47 → 50 (+3)
6.45% less ownership
Funds ownership: 68.63% → 62.17% (-6.5%)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
63% less capital invested
Capital invested by funds: $81.6M → $30M (-$51.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$1.84M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$492K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$487K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$223K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$3.06M |
| 2 |
RA
Royce & Associates
New York
|
-$3.02M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.07M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$732K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$724K |
TELA Hedge Fund Activity: Q1 2025 in Review
50 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2025, worth a combined $30M — down 63% from $81.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TELA positions and 11 closed out — a net gain of 3 holders — while 11 added to existing stakes and 15 trimmed.
The largest buyer was Velan Capital Investment Management, opening a new position worth an estimated $1.84M. The largest seller was AIGH Capital Management, cutting an estimated $3.06M.
- 50 institutional investors held TELA Bio (TELA) as of Q1 2025, up from 47 in Q4 2024.
- Funds reported $30M of TELA Bio stock for Q1 2025, down 63% quarter-over-quarter.
- 14 funds opened new TELA Bio positions in Q1 2025 and 11 closed out, a net change of +3 holders.
- The largest TELA Bio buyer in Q1 2025 was Velan Capital Investment Management, an estimated $1.84M added.
- The largest TELA Bio seller in Q1 2025 was AIGH Capital Management, an estimated $3.06M sold.
Based on aggregated 13F filings for Q1 2025.